A worldwide release of clinical results from Martin Fellows at Tongji Hospital for the benefit of cervical cancer patients

(third from left, Martin)"replace the international standard of synchronous chemotherapy with simple chemotherapy, the efficacy remains unchanged, cervical cancer patients can still retain ovarian function after the removal of the uterus." "This is the first prospective clinical study of cervical cancer iii in China published by Professor Martin of Tongji Hospital, a member of the Chinese Academy of Engineering, at the 2018 American Gynaecological Oncology Annual Meeting (SGO) at the international top eventThe study has attracted wide spread attention from international peers"Not just to prolong life, but to focus more on the quality of life of patientsThis research is very meaningfulProfessor Bradley JMonk, medical director of the Gynaecology Project Group at the American Academy of Oncology and a gynecologist at the University of Arizona, USAFebruary 2018, the 42-year-old patient sent a thank-you note to Fellow Martin, who wrote: "I didn't expect to have my uterus removed, I could be a woman and live like a normal person." "Five years ago due to cervical cancer to remove the uterus, under the guidance of the Ma academician, give up the international standard program of simultaneous chemotherapy, choose simple chemotherapy, return to normal life, she does not forget to send a letter to the Ma academician every yearat present, the incidence of cervical cancer gradually showed a younger trend, compared to 2000, the age of onset of 5-10 years, for young patients, life-saving at the same time how to retain reproductive function has become China's expert thinkingTen years ago, Martin's team of academicians gave new auxiliary chemotherapy to early cervical cancer patients, only to be cut after the lesions were reduced, to preserve the uterus, to preserve fertility function for 100 patients, and more than 20 cervical cancer patients successfully gave birth to healthy babiesHowever, for early cervical cancer patients who have to have their uterus removed and have risk factors after surgery, how to improve their quality of life is easy to be overlookedAccording to international guidelines, if there are high-risk relapse factors such as lymphatic metastasis and vein attack, synchronous chemotherapy is required after surgeryRadiotherapy rays on women's ovaries and other reproductive organs have devastating damage, especially for patients around 40 to 45 years old, prone to early fever, night sweats, insomnia, temper and other menopausal conditions, but also easy to lead to vaginal contractions, sexual disorders, etc, seriously affect the quality of life" the past U.SNational Comprehensive Cancer Network (NCCN) guidelines recommended mostly from foreign clinical research, in fact, Asia is the highest incidence of cervical cancer, especially in China about one-third of cases, so to do cervical cancer clinical research, China is the most powerful and most urgent, Chinese disease or rely on Chinese experts to solve Academician Martin said "Successful treatment not only prolongs life, but also preserves the quality of life of patients." after more than six years of center research, 357 samples of practical analysis, the preliminary results found that early cervical cancer has high-risk recurrence factors in patients after the removal of the uterus, the survival rate of the use of "pure chemotherapy" compared with the international standard recommended "synchronous chemotherapy", but also to avoid radiation damage to the patient's reproductive system, save ovarian function, greatly improve the quality of life of women it is understood that the study is the world's first for early cervical cancer after a wide-ranging hysterectomy has high-risk factors of patients, with auxiliary chemotherapy compared with the current international standard of synchronous chemotherapy for the prospective randomization, control, double-blind phase III non-disadvantaged study, the preliminary results show that cervical cancer patients after the removal of the uterus is still expected to retain ovarian function currently, less than 5 per cent of the data available to international guidelines from Chinese research In 2010, Academician Martin initiated the leadership of the China Middle East Region Gynaecological Oncology Collaboration Group (C-SEM GOG) to carry out multi-center clinical research on gynecological oncology The data for this study are the result of multicenter collaboration "This study is of great significance for cervical cancer patients and we believe it will have a great impact on the world, and we hope to push our treatment program stoking our treatment as A-level evidence to international guidelines that will benefit patients around the world and contribute to the world's experience and wisdom," Martin said "
(Source: Chutian Metropolis Daily reporter Chen Wei, correspondent Li Yunxi)